Vertex Pharmaceuticals Inc (VRTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $136.35B
Last updated: Nov 17, 2026 at 4:39 PM ET
Vertex Pharmaceuticals Inc (VRTX) Stock Chart
Vertex Pharmaceuticals (VRTX) has a latest price of $534.20 on Nov 17, 2026, 6.1% below its 52-week high of $568.67. Its price rose 22.2% over the past 12 months. The month-end price rose 636.7% over the 10 years through Oct 2026, a compound annual rate of 22.1%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $558.88 in Oct 2026 and its lowest $73.67 in Dec 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart VRTX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for VRTX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 3.2%, and over 6 months it rose 23.0%. The month-end price rose 54.3% over the 3 years through Oct 2026, a compound annual rate of 15.6%.
| Period | Change |
|---|---|
| 1 month | +6.4% |
| 3 months | -3.2% |
| 6 months | +23.0% |
| 12 months | +22.2% |
| 12 months, with dividends | +22.2% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +54.3% | +15.6% |
| 5 years | +202.2% | +24.8% |
| 10 years | +636.7% | +22.1% |
Price by Year
Its best calendar year was 2017, when the price rose 103.4%, and its weakest was 2021, when it fell 7.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $558.88 | +23.3% |
| 2025 | $453.36 | +12.6% |
| 2024 | $402.70 | -1.0% |
| 2023 | $406.89 | +40.9% |
| 2022 | $288.78 | +31.5% |
| 2021 | $219.60 | -7.1% |
| 2020 | $236.34 | +7.9% |
| 2019 | $218.95 | +32.1% |
| 2018 | $165.71 | +10.6% |
| 2017 | $149.86 | +103.4% |
Trading Range
The price is 2.3% above its 50-day average of $522.31 and 10.4% above its 200-day average of $483.99.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $534.20 | |
| 52-week high | $568.67 | -6.1% |
| 52-week low | $412.27 | +29.6% |
| 50-day average | $522.31 | +2.3% |
| 200-day average | $483.99 | +10.4% |
Price Risk
Over 3 years, its largest fall from a peak was 29.1%.
| Measure | Value |
|---|---|
| 1-year beta | 0.43 |
| Largest fall, 1 year | -15.2% |
| Largest fall, 3 years | -29.1% |
Valuation
Vertex Pharmaceuticals traded at 24.6x earnings at the end of 2025, against a 5-year median of 23.7x and a 10-year median of 27.0x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About VRTX
What is VRTX's 1-year price change?
Vertex Pharmaceuticals's price rose 22.2% over the past 12 months. With dividends included, the 12-month total return was 22.2%.
What is VRTX's 5-year price change?
Vertex Pharmaceuticals's month-end price rose 202.2% over the 5 years through Oct 2026, a compound annual rate of 24.8%. These figures leave out dividends.
What is VRTX's 52-week high and low?
Vertex Pharmaceuticals's 52-week high is $568.67 and its 52-week low is $412.27. Its latest price of $534.20 on Nov 17, 2026 is 6.1% below the high.
What is VRTX's beta?
Vertex Pharmaceuticals's 1-year beta against the S&P 500 is 0.43, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 15.2%.
Is the VRTX chart free?
Yes. Advanced Charting for VRTX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
VRTX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors